- Home
- XNCR vs IVT Comparison
XNCR vs IVT Comparison
Compare XNCR & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | IVT |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2013 | 2005 |
Fundamental Metrics
Financial Performance| Metric | XNCR | IVT |
|---|---|---|
| Price | $29.82 | $30.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $41.58 | $35.50 |
| AVG Volume (30 Days) | ★ 1.5M | 626.7K |
| Earning Date | 11-13-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.22% |
| EPS Growth | 65.36 | ★ 647.37 |
| EPS | N/A | ★ 0.33 |
| Revenue | $125,576,000.00 | ★ $299,169,000.00 |
| Revenue This Year | $18.52 | $12.43 |
| Revenue Next Year | N/A | $6.69 |
| P/E Ratio | ★ N/A | $93.82 |
| Revenue Growth | ★ 13.65 | 9.20 |
| 52 Week Low | $10.38 | $26.81 |
| 52 Week High | $33.60 | $37.22 |
Technical Indicators
Market Signals| Indicator | XNCR | IVT |
|---|---|---|
| Relative Strength Index (RSI) | 65.50 | 57.66 |
| Support Level | $22.80 | $30.42 |
| Resistance Level | $30.61 | $31.71 |
| Average True Range (ATR) | 1.71 | 0.62 |
| MACD | 0.59 | 0.22 |
| Stochastic Oscillator | 61.74 | 81.16 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.